( December 10, 2025, 9:10 AM EST) -- CAMDEN, N.J. — A manufacturer of losartan products has agreed to pay $1,899,000 to settle claims brought against it by consumers and third-party payers (TPPs) who allege in a multidistrict litigation in a New Jersey federal court that the blood pressure medication was contaminated, according to a motion for preliminary approval of the settlement agreement....